[Targeting of nitric oxide-donor and related drugs]

Yao Xue Xue Bao. 2006 Jun;41(6):481-6.
[Article in Chinese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Azo Compounds / chemical synthesis
  • Azo Compounds / pharmacology
  • Cell Line, Tumor
  • Drug Delivery Systems*
  • Humans
  • Liver / metabolism
  • Liver Neoplasms / pathology
  • Nitrates / chemical synthesis
  • Nitrates / pharmacology
  • Nitric Oxide Donors* / chemical synthesis
  • Nitric Oxide Donors* / pharmacology
  • Oleanolic Acid* / analogs & derivatives
  • Oleanolic Acid* / chemical synthesis
  • Oleanolic Acid* / pharmacology
  • Piperazines / chemical synthesis
  • Piperazines / pharmacology
  • Ursodeoxycholic Acid / analogs & derivatives
  • Ursodeoxycholic Acid / chemical synthesis
  • Ursodeoxycholic Acid / pharmacology

Substances

  • 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester
  • Azo Compounds
  • Nitrates
  • Nitric Oxide Donors
  • O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate
  • Piperazines
  • Oleanolic Acid
  • Ursodeoxycholic Acid